Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ZNF521 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA554680
Description
Immunogen sequence: KQDLVKLDIN GLPYGLCAGC VNLSKSASPG INVPPGTNRP GLGQNENLSA IEGKGKVGGL KTRCSSCNVK FESE Highest antigen sequence identity to the following orthologs: Mouse - 88%, Rat - 85%.
The zinc finger protein 521 (ZNF521) is a transcription factor containing an N-terminal transcriptional repressor motif and 30 zinc finger domains. It plays a role in both erythroid cell and osteoblast differentiation during development, inhibiting the activities of early B-cell factor 1 (EBF1) in erythroid cells and Runx2 in osteoblast precursors. ZFP521 binds to both Runx2 and histone deacetylase 3 (HDAC3), promotes their association and antagonizes Runx2 transcriptional activity in a HDAC3-dependent manner, thereby regulating osteoblast differentiation, skeletal development, and bone homeostasis.
Specifications
ZNF521 | |
Polyclonal | |
Unconjugated | |
ZNF521 | |
B930086A16Rik; early hematopoietic zinc finger protein; Ecotropic viral integration site 3 protein; EHZF; Evi3; LIP3; LYST-interacting protein 3; Zfp521; Zinc finger protein 521; Znf521 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
25925 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q96K83 | |
ZNF521 | |
Recombinant protein corresponding to Human ZNF521. Recombinant protein control fragment (Product #RP-93655). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction